I see you are involved in the 4 medicinal cannabis ZLD, IHL, EMD and BOT. Would love to hear your take on which one has the highest chances of success.
from my research I would order them:
1- ZLD, 2 TGA approved products in OZ and US. By the end of 2021, 10 approved products In UK , Germany, US and OZ
Cons: near term stock dilution from US
2- IHL, generates cash from CBD oil sales Circa 600k, possible FDA approvals, stock price passed the 10c and maintained above
3- EMD, it generates income from data sales, data is key to getting approvals, targeting TGA. Only 225 M shares, management owns 60%
4- BOT, it is at the bottom of the list giving it’s disappointing trial result few months ago resulting in the SP to fall 50% in one day.
they are targeting FDA approval though
- Forums
- ASX - By Stock
- EMD
- EMD Research
EMD Research, page-18
-
-
- There are more pages in this discussion • 129 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.8¢ |
Change
-0.004(7.69%) |
Mkt cap ! $20.85M |
Open | High | Low | Value | Volume |
5.2¢ | 5.3¢ | 4.8¢ | $17.85K | 354.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 46060 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.0¢ | 220000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 46060 | 0.048 |
1 | 10659 | 0.047 |
1 | 75000 | 0.046 |
1 | 100000 | 0.045 |
3 | 96500 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.050 | 220000 | 2 |
0.053 | 50000 | 1 |
0.055 | 76850 | 1 |
0.056 | 250000 | 1 |
0.057 | 99729 | 1 |
Last trade - 15.12pm 15/07/2024 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online